血液スクリーニングの世界市場分析:技術別(核酸増幅試験、ELISA、化学発光免疫学的測定法、酵素免疫学的測定法、次世代シーケンシング、ウェスタンブロッティング)、製品別(試薬、装置)、セグメント予測、2013 – 2024...市場調査レポートについてご紹介

【英文タイトル】Blood Screening Market Analysis By Technology (Nucleic Acid Amplification Test, ELISA, Chemiluminescence Immunoassay And Enzyme Immunoassay, Next-Generation Sequencing, And Western Blotting) And By Product (Reagent, Instrument) And Segment Forecasts, 2013 - 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Content

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation and Scope
3.1.1 Market driver analysis
3.1.1.1 Increasing donor screening
3.1.1.2 Increasing Government Initiatives
3.1.1.3 Technological Developments
3.1.2 Market restraint analysis
3.1.2.1 High Cost
3.2 Penetration & Growth Prospects Mapping
3.3 Blood Screening Market – PESTLE Analysis
3.4 Industry Analysis – Porter’s
3.5 Blood screening competitive scenario, 2015
3.5.1 Competitive landscape: Market position analysis (based on products, regional presence and strategic initiatives)
Chapter 4 Blood Screening Market Technology Estimates & Trend Analysis
4.1 Blood Screening Market: Technology Movement Analysis
4.2 Nucleic Acid Amplification Test (NAT)
4.2.1 Nucleic Acid Amplification Test (NAT) market estimates and forecasts, 2013 – 2024 (USD Million)
4.3 ELISA
4.3.1 ELISA market estimates and forecasts, 2013 – 2024 (USD Million)
4.4 Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
4.4.1 Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA) market estimates and forecasts, 2013 – 2024 (USD Million)
4.5 Next-Generation Sequencing (NGS)
4.5.1 Next-generation sequencing (NGS) market estimates and forecasts, 2013 – 2024 (USD Million)
4.6 Western Blotting
4.6.1 Western blotting market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter 5 Blood Screening Market Product Estimates & Trend Analysis
5.1 Blood Screening Market: Product Movement Analysis
5.2 Reagent
5.2.1 Reagent market estimates and forecasts, 2013 – 2024 (USD Million)
5.3 Instrument
5.3.1 Instrument market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter 6 Blood Screening Market Regional Estimates & Trend Analysis
6.1 Regional Movement Analysis & Market Share, 2015 & 2024
6.2 North America
6.2.1 North America blood screening market, by technology, 2013 – 2024 (USD Million)
6.2.2 North America blood screening market, by product, 2013 – 2024 (USD Million)
6.2.3 U.S.
6.2.3.1 U.S. blood screening market, by technology, 2013 – 2024 (USD Million)
6.2.3.2 U.S. blood screening market, by product, 2013 – 2024 (USD Million)
6.2.4 Canada
6.2.4.1 Canada blood screening market, by technology, 2013 – 2024 (USD Million)
6.2.4.2 Canada blood screening market, by product, 2013 – 2024 (USD Million)
6.3 Europe
6.3.1 Europe blood screening market, by technology, 2013 – 2024 (USD Million)
6.3.2 Europe blood screening market, by product, 2013 – 2024 (USD Million)
6.3.3 Germany
6.3.3.1 Germany blood screening market, by technology, 2013 – 2024 (USD Million)
6.3.3.2 Germany blood screening market, by product, 2013 – 2024 (USD Million)
6.3.4 UK
6.3.4.1 UK blood screening market, by technology, 2013 – 2024 (USD Million)
6.3.4.2 UK blood screening market, by product, 2013 – 2024 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific blood screening market, by technology, 2013 – 2024 (USD Million)
6.4.2 Asia Pacific blood screening market, by product, 2013 – 2024 (USD Million)
6.4.3 Japan
6.4.3.1 Japan blood screening market, by technology, 2013 – 2024 (USD Million)
6.4.3.2 Japan blood screening market, by product, 2013 – 2024 (USD Million)
6.4.4 China
6.4.4.1 China blood screening market, by technology, 2013 – 2024 (USD Million)
6.4.4.2 China blood screening market, by product, 2013 – 2024 (USD Million)
6.4.5 India
6.4.5.1 China blood screening market, by technology, 2013 – 2024 (USD Million)
6.4.5.2 China blood screening market, by product, 2013 – 2024 (USD Million)
6.5 Latin America
6.5.1 Latin America blood screening market, by technology, 2013 – 2024 (USD Million)
6.5.2 Latin America blood screening market, by product, 2013 – 2024 (USD Million)
6.5.3 Brazil
6.5.3.1 Brazil blood screening market, by technology, 2013 – 2024 (USD Million)
6.5.3.2 Brazil blood screening market, by product, 2013 – 2024 (USD Million)
6.5.4 Mexico
6.5.4.1 Mexico blood screening market, by technology, 2013 – 2024 (USD Million)
6.5.4.2 Mexico blood screening market, by product, 2013 – 2024 (USD Million)
6.6 MEA
6.6.1 MEA blood screening market, by technology, 2013 – 2024 (USD Million)
6.6.2 MEA blood screening market, by product, 2013 – 2024 (USD Million)
6.6.3 South Africa
6.6.3.1 South Africa blood screening market, by technology, 2013 – 2024 (USD Million)
6.6.3.2 South Africa blood screening market, by product, 2013 – 2024 (USD Million)
Chapter 7 Competitive Landscape
7.1 Abbott Laboratories
7.1.1 Company overview
7.1.2 Financial performance
7.1.3 Product benchmarking
7.1.4 Strategic initiatives
7.2 Danaher Corporation (Beckman Coulter)
7.2.1 Company overview
7.2.2 Financial performance
7.2.3 Product benchmarking
7.2.4 Strategic initiatives
7.3 Becton Dickinson and Company
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Product benchmarking
7.3.4 Strategic initiatives
7.4 Bio-Rad Laboratories, Inc.
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Product benchmarking
7.4.4 Strategic initiatives
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 Company overview
7.5.2 Financial performance
7.5.3 Product benchmarking
7.5.4 Strategic initiatives
7.6 Grifols
7.6.1 Company overview
7.6.2 Financial performance
7.6.3 Product benchmarking
7.6.4 Strategic Initiatives
7.7 Ortho-Clinical Diagnostics, Inc.
7.7.1 Company overview
7.7.2 Financial performance
7.7.3 Product benchmarking
7.7.4 Strategic initiatives
7.8 SOFINA s.a (Biomérieux)
7.8.1 Company overview
7.8.2 Financial performance
7.8.3 Product benchmarking
7.8.4 Strategic initiatives
7.9 Siemens Healthcare GmbH
7.8.1 Company overview
7.8.2 Financial performance
7.8.3 Product benchmarking
7.8.4 Strategic initiatives
7.10 Thermo Fisher Scientific, Inc
7.10.1 Company overview
7.10.2 Financial performance
7.10.3 Product benchmarking
7.10.4 Strategic initiatives


【レポート販売概要】

■ タイトル:血液スクリーニングの世界市場分析:技術別(核酸増幅試験、ELISA、化学発光免疫学的測定法、酵素免疫学的測定法、次世代シーケンシング、ウェスタンブロッティング)、製品別(試薬、装置)、セグメント予測、2013 – 2024
■ 英文:Blood Screening Market Analysis By Technology (Nucleic Acid Amplification Test, ELISA, Chemiluminescence Immunoassay And Enzyme Immunoassay, Next-Generation Sequencing, And Western Blotting) And By Product (Reagent, Instrument) And Segment Forecasts, 2013 - 2024
■ 発行日:2016年10月28日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707137
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。